Harbin Gloria Pharmaceuticals Co Ltd
SZSE:002437

Watchlist Manager
Harbin Gloria Pharmaceuticals Co Ltd Logo
Harbin Gloria Pharmaceuticals Co Ltd
SZSE:002437
Watchlist
Price: 3.53 CNY -2.49% Market Closed
Market Cap: ¥7.9B

Profitability Summary

Harbin Gloria Pharmaceuticals Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Harbin Gloria Pharmaceuticals Co Ltd

Margins Comparison
Harbin Gloria Pharmaceuticals Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Harbin Gloria Pharmaceuticals Co Ltd
SZSE:002437
7.9B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
270B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.4B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.9B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Harbin Gloria Pharmaceuticals Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Harbin Gloria Pharmaceuticals Co Ltd
SZSE:002437
7.9B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
270B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.4B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.9B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Harbin Gloria Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate